NORPRAMIN Trademark

Trademark Overview


On Wednesday, November 1, 2023, a trademark application was filed for NORPRAMIN with the United States Patent and Trademark Office. The USPTO has given the NORPRAMIN trademark a serial number of 98250480. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, June 18, 2024. This trademark is owned by Validus Pharmaceuticals LLC. The NORPRAMIN trademark is filed in the Pharmaceutical Products category with the following description:

Psychopharmacologic medication and preparations
norpramin

General Information


Serial Number98250480
Word MarkNORPRAMIN
Filing DateWednesday, November 1, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, June 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPsychopharmacologic medication and preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 16, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameValidus Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Saturday, November 4, 2023NEW APPLICATION ENTERED
Wednesday, June 12, 2024ASSIGNED TO EXAMINER
Tuesday, June 18, 2024NON-FINAL ACTION E-MAILED
Tuesday, June 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 18, 2024NON-FINAL ACTION WRITTEN
Wednesday, September 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED